The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials

The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials

The signal transducer and activator of transcription 1 (STAT1) is a transducer protein and acts as a transcription factor but its role in ovarian cancer (OC) is not completely understood. Practically, there are two-faced effects of STAT1 on tumorigenesis in different kinds of cancers. Existing evide...

Full description

Bibliographic Details
Main Authors:	Xin Li, Fanchen Wang, Xiaolin Xu, Jinguo Zhang, Guoxiong Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	chemoresistance immune response microenvironment tumorigenesis signaling pathway stemness
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.636595/full

Similar Items

Predicting STAT1 as a prognostic marker in patients with solid cancer
by: Jinguo Zhang, et al.
Published: (2020-05-01)

Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer
by: Lingyun Zhang, et al.
Published: (2021-07-01)

Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer
by: Jinguo Zhang, et al.
Published: (2020-09-01)

Effects of CAF-Derived MicroRNA on Tumor Biology and Clinical Applications
by: Xu Wang, et al.
Published: (2021-06-01)

Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions
by: Xin Zhang, et al.
Published: (2019-01-01)

The Implications of Cancer Stem Cells for Cancer Therapy
by: Wenjing Jiang, et al.
Published: (2012-12-01)

Exosomes: A New Pathway for Cancer Drug Resistance
by: Yunbin Zhong, et al.
Published: (2021-09-01)

Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer
by: Zhongbo Zhang, et al.
Published: (2021-05-01)

CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
by: Antons Martincuks, et al.
Published: (2020-12-01)

Signaling Pathways Driving Aberrant Splicing in Cancer Cells
by: Vânia Gonçalves, et al.
Published: (2017-12-01)

The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
by: Chang Liu, et al.
Published: (2021-09-01)

Exploitation of Apoptotic Regulation in Cancer
by: David S. Ucker, et al.
Published: (2018-02-01)

Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to Gemcitabine
by: Gang Zhao, et al.
Published: (2011-03-01)

Cancer Stem Cells, <i>Quo Vadis</i>? The Notch Signaling Pathway in Tumor Initiation and Progression
by: Christian T. Meisel, et al.
Published: (2020-08-01)

Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
by: Nicole E. James, et al.
Published: (2018-04-01)

Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway
by: Liang Yang, et al.
Published: (2018-08-01)

The role of the Hedgehog signaling pathway in cancer: A comprehensive review
by: Ana Marija Skoda, et al.
Published: (2018-02-01)

MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings
by: Wei Li, et al.
Published: (2019-10-01)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
by: Lynn Roy, et al.
Published: (2018-07-01)

Therapeutics formulated to target cancer stem cells: Is it in our future?
by: Mousa Shaker A, et al.
Published: (2011-03-01)

Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem-like cells leading to a reduced tumor burden
by: Khalid eAbubaker, et al.
Published: (2014-04-01)

Mitochondrial Quality Control in Hepatocellular Carcinoma
by: Jinda Bian, et al.
Published: (2021-09-01)

33-kDa ANXA3 isoform contributes to hepatocarcinogenesis via modulating ERK, PI3K/Akt-HIF and intrinsic apoptosis pathways
by: Chunmei Guo, et al.
Published: (2021-05-01)

Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer
by: Wang M, et al.
Published: (2021-04-01)

CIRBP Knockdown Attenuates Tumourigenesis and Improves the Chemosensitivity of Pancreatic Cancer via the Downregulation of DYRK1B
by: Xiang Chen, et al.
Published: (2021-08-01)

Galectins and Ovarian Cancer
by: Chisa Shimada, et al.
Published: (2020-05-01)

STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
by: Yuan-Yu Wu, et al.
Published: (2018-08-01)

Signaling pathways governing breast cancer stem cells behavior
by: Kai Song, et al.
Published: (2021-04-01)

Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications
by: Reza Jafari, et al.
Published: (2020-12-01)

The role of collagen in cancer: from bench to bedside
by: Shuaishuai Xu, et al.
Published: (2019-09-01)

Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
by: Jean-Pierre Delord, et al.
Published: (2012-07-01)

Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
by: Weilong Chen, et al.
Published: (2018-09-01)

Cancer Stem Cells and Targeting Strategies
by: Luisa Barbato, et al.
Published: (2019-08-01)

Targeting stem cells in the realm of drug-resistant breast cancer
by: Dey P, et al.
Published: (2019-03-01)

mTOR at the Transmitting and Receiving Ends in Tumor Immunity
by: Yakir Guri, et al.
Published: (2018-03-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01)

NF-κB in Gastric Cancer Development and Therapy
by: Supattra Chaithongyot, et al.
Published: (2021-07-01)

CDC20 Knockdown and Acidic Microenvironment Collaboratively Promote Tumorigenesis through Inhibiting Autophagy and Apoptosis
by: Qingying Gu, et al.
Published: (2020-06-01)

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
by: Niels E. Wondergem, et al.
Published: (2021-03-01)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
by: Ping-Lian Yang, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_538iphvs5n5v4qpuoetl5774sf